Investors are fearful RFK Jr.'s critical stance on weight loss drugs could impact pricing or Medicare coverage, but BMO says ...

A study using a Korean database found that COVID-19 infection raised long-term risks for various autoimmune and ...

With the recent spike in implied volatility, an iron condor on Amgen can use short strikes with a wide profit range.

Dramatic study results point to the potential for a steroid-sparing option for patients with the underrecognized multiorgan ...

Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after ...

Despite the very positive setup facing Amgen as a result of its ongoing and future investments in developing new ...

Analyzing Amgen's stock drop, management's response, and potential for growth in GLP-1 candidate MariTide in a volatile ...

Amgen Inc. may ultimately have to pay as much as $10.7 billion in taxes, interest and penalties to the IRS—nearly as much as ...

The excitement around the new weight-loss industry is overtaking other disease areas and portfolios for publicly traded ...

We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at ...

Amgen’s stock fell 7% after an analyst posted a note on MariTide’s influence on bone density which was noticed in a data ...

Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.